louisiana glp-1 bowel obstruction class action Receptor Agonists in Diabetes and Obesity: A Case Report and Review of Risks and Management FDA Adds Intestinal Blockage Reports

extending into the early 2030s, Novo Nordisk's core semaglutide patent has lapsed in Canada

AMPK is a regulatory enzyme that functions as the master cellular energy regulator, and Actiponin's damulin compounds have been studied for their role in activating it leading to increased fat oxidation and reduced fat storage at the cellular level

The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in high U.S

Euglycemic diabetic ketoacidosis (EDKA) is a rare but potentially life-threatening condition that presents with metabolic acidosis and ketonemia in the absence of hyperglycemia